SCHEMBL20503286

SCHEMBL20503286

CCCCc1ccc(C)c(C(=O)O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT8 Q9H7Z6 2/20 0.62
PPARA Q07869 2/20 0.58
RARB P10826 5/20 0.56
PPARG P37231 1/20 0.54
METAP2 P50579 1/20 0.53
ALDH1A1 P00352 2/20 0.53
CYP3A4 P08684 2/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
MAPT P10636 1/20 0.53
PKM P14618 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
THPO P40225 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL551744 0.86 RARB (0.68) KAT8PPARARARBPPARGMETAP2
SCHEMBL24159779 0.86 KAT8 (0.50) KAT8PPARARARBPPARGMETAP2
SCHEMBL1356365 0.86 KAT8 (0.66) KAT8PPARARARBPPARGMETAP2
SCHEMBL9791064 0.85 SMN1; SMN2 (0.51) KAT8PPARARARBMETAP2ALOX15
SCHEMBL28399319 0.83 KAT8 (0.48) KAT8PPARARARBPPARGMETAP2
SCHEMBL30748696 0.83 KAT8 (0.88) KAT8PPARARARBPPARGMETAP2
SCHEMBL2532041 0.83 KAT8 (0.88) KAT8PPARARARBPPARGMETAP2
SCHEMBL7455122 0.82 LCK (0.47) KAT8PPARARARBALDH1A1KDM4E
SCHEMBL17586553 0.82 GRIN2D (0.58) KAT8PPARARARBPPARGMETAP2
SCHEMBL13652492 0.82 ALDH1A1 (0.50) KAT8RARBMETAP2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3377473-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2024-06-19 EP disclosed
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
CN-108884058-B Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2022-04-29 CN disclosed
CN-108884058-A MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS 阿奇克斯制药公司 2018-11-23 CN disclosed
US-20180327367-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS WUXI APPTEC CO., LTD (CN) 2018-11-15 US disclosed
EP-3377473-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX Pharmaceuticals, Inc. (US) 2018-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180327367-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC KAT8 4090/4885PPARA 3021/4885RARB 1554/4885
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC KAT8 4090/4885PPARA 3021/4885RARB 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.